Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Colonic Neoplasms × Laparoscopy × Clear all

Phase

Status

Unknown 6 Completed 3 Terminated 1 Recruiting 1 Not yet recruiting 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Polycystic Ovary Syndrome 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Oxaliplatin 7 Fluorouracil 4 tislelizumab 3 Irinotecan 3 raltitrexed 2 pembrolizumab 2 Leucovorin 2 Chemotherapy, Adjuvant 2 Capecitabine 2 spartalizumab 1 sintilimab 1 rimegepant sulfate 1 encorafenib 1 cemiplimab 1 XELOX 1 Surgical Procedures, Operative 1 Radiofrequency Ablation 1 Preoperative Exercise 1 Neoadjuvant Therapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mortality 1 Laparoscopy 1 Immune Checkpoint Inhibitors 1 HMPL-013 1 HLX07 1 Genetic Testing 1 Everolimus 1 Drug Therapy 1 Diagnostic Tests, Routine 1 Conversion to Open Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07314996 2026-01-02

LOVO

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Not yet recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡